CN103520107B - 一种阴道填塞泡沫剂 - Google Patents
一种阴道填塞泡沫剂 Download PDFInfo
- Publication number
- CN103520107B CN103520107B CN201310470909.9A CN201310470909A CN103520107B CN 103520107 B CN103520107 B CN 103520107B CN 201310470909 A CN201310470909 A CN 201310470909A CN 103520107 B CN103520107 B CN 103520107B
- Authority
- CN
- China
- Prior art keywords
- treatment
- vaginal plugging
- stirring
- plugging foam
- foam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000006260 foam Substances 0.000 title claims abstract description 25
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims abstract description 10
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003380 propellant Substances 0.000 claims abstract description 8
- 239000001282 iso-butane Substances 0.000 claims abstract description 5
- 235000013847 iso-butane Nutrition 0.000 claims abstract description 5
- IJDNQMDRQITEOD-UHFFFAOYSA-N sec-butylidene Natural products CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract 2
- 238000003756 stirring Methods 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 229910052709 silver Inorganic materials 0.000 claims description 7
- 239000004332 silver Substances 0.000 claims description 7
- 229910000166 zirconium phosphate Inorganic materials 0.000 claims description 7
- LEHFSLREWWMLPU-UHFFFAOYSA-B zirconium(4+);tetraphosphate Chemical compound [Zr+4].[Zr+4].[Zr+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LEHFSLREWWMLPU-UHFFFAOYSA-B 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- 102000016359 Fibronectins Human genes 0.000 claims description 3
- 108010067306 Fibronectins Proteins 0.000 claims description 3
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 claims description 3
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 229930014456 matrine Natural products 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 230000008961 swelling Effects 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 claims 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 claims 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 8
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 206010046914 Vaginal infection Diseases 0.000 description 11
- 210000001215 vagina Anatomy 0.000 description 11
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 201000008100 Vaginitis Diseases 0.000 description 6
- 206010008323 cervicitis Diseases 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 5
- 230000003628 erosive effect Effects 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000006374 Uterine Cervicitis Diseases 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 201000003988 chronic cervicitis Diseases 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108091007643 Phosphate carriers Proteins 0.000 description 2
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000002893 slag Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 102000016462 Phosphate Transport Proteins Human genes 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- IJRVLVIFMRWJRQ-UHFFFAOYSA-N nitric acid zinc Chemical compound [Zn].O[N+]([O-])=O IJRVLVIFMRWJRQ-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310470909.9A CN103520107B (zh) | 2013-10-11 | 2013-10-11 | 一种阴道填塞泡沫剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310470909.9A CN103520107B (zh) | 2013-10-11 | 2013-10-11 | 一种阴道填塞泡沫剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103520107A CN103520107A (zh) | 2014-01-22 |
CN103520107B true CN103520107B (zh) | 2016-08-17 |
Family
ID=49922698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310470909.9A Expired - Fee Related CN103520107B (zh) | 2013-10-11 | 2013-10-11 | 一种阴道填塞泡沫剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103520107B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9884049B2 (en) | 2014-07-14 | 2018-02-06 | Orion Biotechnology Canada Ltd. | Microbicidal composition comprising an octoxynol and a quinolizidine alkaloid compound or a source thereof |
CN105749277A (zh) * | 2016-03-10 | 2016-07-13 | 陕西瑞凯生物科技有限公司 | 一种卵黄生物蛋白泡沫填塞剂及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1762488A (zh) * | 2005-10-08 | 2006-04-26 | 张怡 | 人细胞纤连蛋白的外用药物组合物及其制备方法 |
CN101062055A (zh) * | 2007-06-06 | 2007-10-31 | 崔彬 | 一种缓释型纳米银抗菌凝胶剂及其制备方法与应用 |
CN102872159A (zh) * | 2012-09-29 | 2013-01-16 | 广东同德药业有限公司 | 一种治疗阴道细菌性炎症的纳米银壳聚糖凝胶泡沫制剂及其制备方法 |
-
2013
- 2013-10-11 CN CN201310470909.9A patent/CN103520107B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1762488A (zh) * | 2005-10-08 | 2006-04-26 | 张怡 | 人细胞纤连蛋白的外用药物组合物及其制备方法 |
CN101062055A (zh) * | 2007-06-06 | 2007-10-31 | 崔彬 | 一种缓释型纳米银抗菌凝胶剂及其制备方法与应用 |
CN102872159A (zh) * | 2012-09-29 | 2013-01-16 | 广东同德药业有限公司 | 一种治疗阴道细菌性炎症的纳米银壳聚糖凝胶泡沫制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103520107A (zh) | 2014-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102160887B (zh) | 一种治疗妇科炎症的药物及其制备方法 | |
CN108158995A (zh) | 一种含有壳聚糖的妇科用抗菌泡沫剂及其制备方法 | |
CN103920072A (zh) | 一种壳聚糖抗菌凝胶及其制备方法 | |
SE0950390L (sv) | System och process för tillverkning av en lösning med suspenderade fasta ämnen och användningar därför | |
CN103520107B (zh) | 一种阴道填塞泡沫剂 | |
CN104688786A (zh) | 一种外用药物组合物及其制备方法和用途 | |
CN103316262B (zh) | 一种妇科外用抗菌液及其制备方法 | |
US6146640A (en) | Immune system catalyst | |
CN104888058B (zh) | 一种抑菌、消炎外用制剂及其制备方法 | |
CN102283899B (zh) | 一种中药外用制剂及其用途 | |
CN104473800A (zh) | 婴儿湿纸巾 | |
CN106620814B (zh) | 抗菌护垫 | |
CN105395435A (zh) | 一种基于多离子水的女性专用护理湿巾 | |
CN101829130A (zh) | 复方白藜芦醇抗炎止痒药物组合及用途 | |
CN104490976A (zh) | 一种复方紫草止痒湿疹药物 | |
CN102018780B (zh) | 一种皮肤抑菌剂及其制备方法 | |
CN102755578B (zh) | 一种治疗妇科疾病的洗液及其制备方法 | |
CN103007258A (zh) | 含鱼丝氨酸蛋白酶和抗菌化合物的医用组合物及其用途 | |
Hopkins et al. | Fungistatic agents for treatment of dermatophytosis | |
CN102988844A (zh) | 一种妇科凝胶剂及其提取方法 | |
CN102397307A (zh) | 一种复方水包油型蛇床子油纳米乳组合物及其制备方法 | |
CN109091596A (zh) | 一种女性用复方护理凝胶及其制备方法 | |
CN103622839B (zh) | 一种女性护理用卫生湿纸巾 | |
CN102462768A (zh) | 一种女性外用护理液 | |
CN102824542A (zh) | 一种烧伤生肌膏 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160408 Address after: 211505 D7 building, Zhongshan Science Park, Liuhe District, Jiangsu, Nanjing Applicant after: NANJING YAFANG PHARMACEUTICAL Co.,Ltd. Address before: 222200, No. 3-3, salt transportation road, Yi Town, Guanyun County, Lianyungang, Jiangsu Applicant before: Xu Kezhi |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: NANJING YAFANG PHARMACEUTICAL Co.,Ltd. Person in charge of patentsThe principal of patent Document name: payment instructions |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: NANJING YAFANG PHARMACEUTICAL Co.,Ltd. Person in charge of patentsThe principal of patent Document name: Notice of Termination of Patent Rights |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 |